-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QVa+rjTMrypauf4dpoLl7KoLEdzYHnoGYvXZZoR1+MSIqciFEWoUHDesiq3XDG5Y rqziMzhLB/tk/thUsMASow== 0001024739-99-000683.txt : 19991123 0001024739-99-000683.hdr.sgml : 19991123 ACCESSION NUMBER: 0001024739-99-000683 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19991122 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-43408 FILM NUMBER: 99762174 BUSINESS ADDRESS: STREET 1: 901 MARINERS ISLAND BLVD STREET 2: SUITE 315 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 6503583456 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HALIFAX FUND LP CENTRAL INDEX KEY: 0001075674 STANDARD INDUSTRIAL CLASSIFICATION: [] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O THE PALLADIN GROUP INC STREET 2: 40 WEST 57TH STREET CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2126980500 SC 13G 1 SCHEDULE 13G ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* SciClone Pharmaceuticals, Inc. ------------------------------------------------------ (Name of Issuer) Common Stock, no par value ------------------------------------------------------ (Title of Class of Securities) 80862K104 ------------------------------------------------------ (CUSIP Number) November 9, 1999 ------------------------------------------------------ (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |X| Rule 13d-1(c) |_| Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. ================================================================================ Page 1 of 4 Pages CUSIP No. 80862K104 13G Page 2 of 4 Pages - -------------------------------------------------------------------------------- (1) NAME OF REPORTING PERSON Halifax Fund, L.P. - -------------------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- (3) SEC USE ONLY - -------------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands - -------------------------------------------------------------------------------- (5) SOLE VOTING POWER 1,190,185 ------------------------------------------------------ NUMBER OF (6) SHARED VOTING POWER SHARES 0 BENEFICIALLY ------------------------------------------------------ OWNED BY (7) SOLE DISPOSITIVE POWER EACH 1,190,185 REPORTING ------------------------------------------------------ PERSON WITH (8) SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,190,185 - -------------------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.6% - -------------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON: 00 - -------------------------------------------------------------------------------- AMENDMENT NO. 1 TO SCHEDULE 13G The Schedule 13G, dated December 30, 1998, of Halifax Fund, L.P. (the "Reporting Person") is hereby amended as set forth below. The purpose of this Amendment No. 1 to Schedule 13G is to update information regarding Halifax Fund, L.P.'s holdings in securities of the issuer as described herein. Except as specifically provided herein, this Amendment No. 1 to Schedule 13G does not modify any of the information previously reported in the Schedule 13G, and should be read in conjunction with, and is qualified in its entirety by reference to, the Schedule 13G. Item 4 is hereby amended as set forth below: Item 4. Ownership. - ------- --------- (a) Amount Beneficially Owned: 1,190,185 (b) Percent of Class: 4.6% (c) Number of Shares to which such person has: (i) Sole power to vote or direct the vote: 1,190,185 (ii) Shared power to vote or direct the vote: 0 (iii) Sole power to dispose or to direct the deposition of: 1,190,185 (iv) Shared power to dispose or to direct the disposition of: 0 Item 5 is hereby amended as set forth below: Item 5. Ownership of Five Percent or Less of a Class. - ------- --------------------------------------------- If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Page 3 of 4 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 22, 1999 ------------------------------ Date Halifax Fund, L.P. By: The Palladin Group, L.P. Attorney-in-fact By: Palladin Capital Management, L.L.C. General Partner /s/ Robert L. Chender ------------------------------ Signature Robert L. Chender Duly Authorized Signatory ------------------------------ Name/Title Page 4 of 4 Pages -----END PRIVACY-ENHANCED MESSAGE-----